Search research articles
Contact Us
Filters
Showing results (11-20 of 234) with videos related to
Page
of 24
Sort By:
BJU International
|
June 26, 2003
Partin tables: past and present
M A Khan, A W Partin
Urology
|
April 11, 2001
Prostate-specific antigen and new serum biomarkers for evaluation of chemopreventive agents
A W Partin, L S Marks
The Journal of Urology
|
July 1, 1994
Re: The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer
A W Partin, P C Walsh
Reviews in Urology
|
September 21, 2006
Hereditary and familial prostate cancer: biologic aggressiveness and recurrence
S R Potter, A W Partin
Reviews in Urology
|
September 21, 2006
Prostate biopsy schemes and the detection of prostate cancer
S R Potter, A W Partin
Current Urology Reports
|
June 27, 2002
What does prostate-specific antigen recurrence mean?
C R Pound, A W Partin
Seminars in Roentgenology
|
December 20, 1999
Prostatitis syndromes and benign prostatic hyperplasia
S R Potter, A W Partin
The Urologic Clinics of North America
|
October 10, 2001
Indicators of pathologic stage of prostate cancer and their use in clinical practice
M R Feneley, A W Partin
Recent Progress in Hormone Research
|
January 1, 1994
Benign and malignant prostatic neoplasms: human studies
A W Partin, D S Coffey
The Urologic Clinics of North America
|
November 1, 1996
The use of prostate-specific antigen and free/total prostate-specific antigen in the diagnosis of localized prostate cancer
A W Partin, H B Carter
Page
of 24
Search research articles
Search
Showing results (11-20 of 234) with videos related to
Sort By:
Page
of 24
BJU International
|
June 26, 2003
Partin tables: past and present
M A Khan, A W Partin
Urology
|
April 11, 2001
Prostate-specific antigen and new serum biomarkers for evaluation of chemopreventive agents
A W Partin, L S Marks
The Journal of Urology
|
July 1, 1994
Re: The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer
A W Partin, P C Walsh
Reviews in Urology
|
September 21, 2006
Hereditary and familial prostate cancer: biologic aggressiveness and recurrence
S R Potter, A W Partin
Reviews in Urology
|
September 21, 2006
Prostate biopsy schemes and the detection of prostate cancer
S R Potter, A W Partin
Current Urology Reports
|
June 27, 2002
What does prostate-specific antigen recurrence mean?
C R Pound, A W Partin
Seminars in Roentgenology
|
December 20, 1999
Prostatitis syndromes and benign prostatic hyperplasia
S R Potter, A W Partin
The Urologic Clinics of North America
|
October 10, 2001
Indicators of pathologic stage of prostate cancer and their use in clinical practice
M R Feneley, A W Partin
Recent Progress in Hormone Research
|
January 1, 1994
Benign and malignant prostatic neoplasms: human studies
A W Partin, D S Coffey
The Urologic Clinics of North America
|
November 1, 1996
The use of prostate-specific antigen and free/total prostate-specific antigen in the diagnosis of localized prostate cancer
A W Partin, H B Carter
Page
of 24